Top Markets
#1 Islamic Coin Islamic Coin +151.49%
#2 Akedo Akedo +48.65%
#3 DOVU DOVU +48.14%
#4 Velvet Velvet +43.34%
#5 Black Phoenix Black Phoenix +33.95%
#6 Cross Cross +24.30%
#7 Cap Cap +20.40%
#8 DoubleZero DoubleZero +15.97%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.98%
#10 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +9.29%
Coin of the day
Islamic Coin Islamic Coin
Instellingen
Taal
DUTCH
Valuta
USD
Thema
BBS-Bioactive Bone Substitutes Oyj BBS-Bioactive Bone Substitutes Oyj

BBS-Bioactive Bone Substitutes Oyj

BONEH
Rang in aandelen #39434
BBS-Bioactive Bone Substitutes Oyj operates as a Finnish biomedical technology... BBS-Bioactive Bone Substitutes Oyj operates as a Finnish biomedical technology firm, dedicated to innovating, manufacturing, and commercializing bioactive medical devices and implants for orthopedic surgical applications. The company's key offering, ARTEBONE, is an orthobiological product composed of tricalcium phosphate and a comprehensive spectrum of natural bone proteins. This solution is predominantly used for addressing bone deficiencies and aiding healing processes, especially in extremities such as the foot and ankle. BBS-Bioactive Bone Substitutes Plc commenced operations in 1991 and has its corporate headquarters situated in Oulu, Finland.
Aandeelprijs
$0.05828914
Laatst gesynchroniseerd: 2025-03-10
Marktkapitalisatie
$495.40K
Verandering (1 dag)
-0.02%
Verandering (1 jaar)
0.00%
Land
FI
Handel BBS-Bioactive Bone Substitutes Oyj (BONEH)

Categorie

Healthcare
Winst voor BBS-Bioactive Bone Substitutes Oyj (BONEH)
Winst in 2026 TTM: 0
Volgens de meest recente financiële verslagen van BBS-Bioactive Bone Substitutes Oyj bedraagt de huidige winst van het bedrijf 0. In 2026 behaalde het bedrijf een winst van 0, gelijk aan de winst van 2026, die 0 bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van BBS-Bioactive Bone Substitutes Oyj van 2026 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -
US